CERo Therapeutics Holdings, Inc. (CERO) stock
CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%
CERo Therapeutics total assets
Total assets on the balance sheet at the end of each period.
CERo Therapeutics's total assets was $1.90M at Jun 30, 2026. For fiscal 2025 it was $3.64M, down 41.3% from the year before. The highest annual figure on record is $180.08M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.64M | -41.3% |
| FY2024 | Dec 31, 2024 | $6.21M | +21.1% |
| FY2023 | Dec 31, 2023 | $5.13M | -87.9% |
| FY2022 | Dec 31, 2022 | $42.37M | -76.5% |
| FY2021 | Dec 31, 2021 | $180.08M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.90M | -69.4% |
| Q1 FY2026 | Mar 31, 2026 | $2.21M | -72.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.64M | -41.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.91M | -39.8% |
| Q2 FY2025 | Jun 30, 2025 | $6.20M | -15.9% |
| Q1 FY2025 | Mar 31, 2025 | $7.99M | -11.7% |
| Q4 FY2024 | Dec 31, 2024 | $6.21M | +21.1% |
| Q3 FY2024 | Sep 30, 2024 | $6.49M | -23.4% |
| Q2 FY2024 | Jun 30, 2024 | $7.37M | -47.8% |
| Q1 FY2024 | Mar 31, 2024 | $9.05M | -37.3% |
| Q4 FY2023 | Dec 31, 2023 | $5.13M | -87.9% |
| Q3 FY2023 | Sep 30, 2023 | $8.47M | -95.3% |
| Q2 FY2023 | Jun 30, 2023 | $14.11M | -92.1% |
| Q1 FY2023 | Mar 31, 2023 | $14.43M | -92.0% |
| Q4 FY2022 | Dec 31, 2022 | $42.37M | -76.5% |
| Q3 FY2022 | Sep 30, 2022 | $180.45M | +59850.5% |
| Q2 FY2022 | Jun 30, 2022 | $179.72M | – |
| Q1 FY2022 | Mar 31, 2022 | $179.78M | – |
| Q4 FY2021 | Dec 31, 2021 | $180.08M | – |
| Q3 FY2021 | Sep 30, 2021 | $301.00K | – |
See a number that looks wrong?